CEBPA Mutation Detection Test: Booking, Price, and Results
About CEBPA Mutation Detection Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | CEBPA Mutation Analysis, CEBPA Gene Sequencing, CCAAT/Enhancer Binding Protein Alpha Mutation Test |
| Sample Type | Peripheral blood (venous) and bone marrow aspirate |
| Fasting Required | No |
| Report Time | 12 days |
| Recommended For | All genders; primarily patients with suspected or confirmed acute myeloid leukaemia (AML) |
| Price | Starting at ₹7,500 |
What is a CEBPA Mutation Detection Test?
The CEBPA Mutation Detection Test is a molecular genetic test that analyses the CEBPA gene for disease-causing changes. CEBPA (CCAAT/enhancer binding protein alpha) is a gene that plays a key role in the development of white blood cells. Doctors typically order this test for patients with suspected or confirmed acute myeloid leukaemia (AML) to support diagnosis and assess prognosis. Also known as CEBPA Mutation Analysis or CEBPA Gene Sequencing, the test uses either a peripheral blood sample or a bone marrow aspirate.
What Does a CEBPA Mutation Detection Test Measure?
The test analyses specific changes in the CEBPA gene. Understanding these changes helps doctors classify the disease and plan care. The key targets are listed below.
| Component | What It Means |
|---|---|
| CEBPA gene mutations | Changes in a gene that controls how certain white blood cells develop and mature |
| Single (monoallelic) mutations | A change affecting only one copy of the CEBPA gene |
| Double (biallelic) mutations | Changes in both copies of the CEBPA gene; associated with a more favourable outlook in AML |
| N-terminal mutations | Frameshift mutations that cause the protein to be cut short at one end |
| C-terminal bZIP domain mutations | Small insertions or deletions in the region that controls how the protein binds to DNA |
Why is a CEBPA Mutation Detection Test Done?
This test is ordered when a doctor needs to confirm a diagnosis of AML, classify the disease type, or understand how a patient's condition may progress. The sections below outline the situations in which it is commonly requested.
Common Symptoms That May Require This Test
Doctors may recommend the CEBPA Mutation Detection Test when a patient presents with one or more of the following symptoms.
- Frequent or severe infections due to a low white blood cell count
- Persistent fatigue and weakness linked to anaemia (low red blood cells)
- Unexplained bruising or abnormal bleeding caused by a low platelet count
- Fever without a clear cause
- Unexplained weight loss
Conditions This Test Can Help Detect
The test supports the identification and classification of the following conditions.
- Acute myeloid leukaemia (AML), where CEBPA mutations are found in 6% to 15% of newly diagnosed cases
- AML with a normal karyotype (chromosome pattern), where mutation rates are higher at 15% to 18%
- Familial AML caused by inherited (germline) CEBPA mutations passed down through families
How to Prepare and What to Expect
This test requires careful sample handling and some advanced preparation. The information below covers everything you need to know before your appointment.
Do You Need to Fast?
No fasting is required. You can eat and drink normally before sample collection. There are no food or fluid restrictions for this test.
Practical Tips Before Your Test
Preparing properly helps ensure an accurate result. Keep the following points in mind.
- Bring your detailed clinical history, including your symptoms, previous test results, and family history, as this is required for the test
- Also, bring any histopathology reports you have, as these are required alongside the test
- Inform your doctor about any blood transfusions received recently
- Disclose all current medications, including any chemotherapy drugs
- Stay well hydrated before collection, as this makes the blood draw easier
- Avoid strenuous physical activity on the day of collection
Step-by-Step Procedure
This test collects two types of samples: peripheral blood and bone marrow. Here is what to expect at each stage.
Peripheral Blood Collection
- A trained phlebotomist cleans the inside of your elbow with an antiseptic.
- A needle is inserted into a vein to draw a 3 ml blood sample into a lavender-top (EDTA) tube.
- The needle is removed, and a cotton pad or bandage is applied to the site.
Bone Marrow Collection
- A haematologist (blood specialist) performs this procedure, typically at the hip bone.
- The area is cleaned, and a local anaesthetic is applied to numb the skin and bone surface.
- A special needle is inserted to draw approximately 3 ml of bone marrow into a green-top sodium heparin tube.
- You may feel brief pressure or mild discomfort during the procedure. This is normal.
Both samples are labelled, stored at 2 to 8 degrees Celsius, and dispatched to the molecular pathology laboratory for NGS analysis.
Factors That Can Affect Accuracy
The following factors may influence the reliability of your test results.
- Delayed processing: samples should be delivered to the laboratory promptly, as stability can decline over time
- Improper storage: samples must never be frozen; they must be refrigerated between 2 and 8 degrees Celsius
- Low white blood cell count in the collected sample, which may reduce DNA yield
- Haemolysis (breakdown of red blood cells) in the sample
- Heparin from certain collection tubes can interfere with some molecular assays if not handled correctly
Understanding Your CEBPA Mutation Detection Test Results
Results are reported as a qualitative finding. Below is a summary of what each outcome typically indicates. Always review your results with your doctor before drawing any conclusions.
| Parameter | Possible Result | Clinical Note |
|---|---|---|
| CEBPA Mutation Status | Not Detected | No mutation found; this does not rule out AML entirely |
| CEBPA Mutation Status | Detected | Mutation identified; type will be specified |
| Mutation Type | Single (monoallelic) | Only one mutation observed; outlook is similar to that of patients with no CEBPA mutation |
| Mutation Type | Double (biallelic) | Two or more mutations detected; associated with a more favourable prognosis in AML |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
How to Maintain Healthy Levels
The following general wellness tips support overall health during and after evaluation.
- Attend all scheduled medical appointments to ensure timely follow-up and monitoring
- Maintain a balanced, nutrient-rich diet to support immune function and general well-being
- Report any new or worsening symptoms, such as unexplained bruising, fatigue, or recurring infections, to your doctor without delay
Lupin Diagnostics CEBPA Mutation Detection Test Price
The CEBPA Mutation Detection Test is available at Lupin Diagnostics starting at ₹7,500. This test requires a visit to a Lupin Diagnostics centre, as home collection is not available for this test.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 7500 |
| CHENNAI | 7500 |
| HYDERABAD | 7500 |
| KOLKATA | 7500 |
| NAVI MUMBAI | 7500 |
| PUNE | 7500 |
Disclaimer: Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps to book the CEBPA mutation detection test online:
- Select the CEBPA Mutation Detection Test on the Lupin Diagnostics website.
- Choose your city and preferred time slot.
- Visit the centre at your scheduled time for sample collection.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
The CEBPA Mutation Detection Test is used to identify gene mutations linked to acute myeloid leukaemia (AML). It helps doctors confirm the diagnosis, classify the disease subtype, and assess how the condition may progress. In some cases, it can also identify inherited (familial) forms of AML.
No fasting is needed. You can eat and drink as usual before your appointment. This is a molecular genetic test and is not affected by food intake.
The report is typically delivered within 12 days. Testing is done using Next Generation Sequencing (NGS), which is a detailed process that requires time for DNA extraction, gene analysis, and result interpretation.
You should bring a detailed clinical history report covering your symptoms and any relevant family history. A histopathology report is also required. Having these documents ready at the time of collection helps ensure accurate interpretation of your results.
A single (monoallelic) mutation affects one copy of the CEBPA gene, and its outlook is generally similar to cases with no mutation at all. A double (biallelic) mutation affects both copies and is associated with a more favourable prognosis in AML patients. Your doctor will explain what the specific finding means for your case.
Yes. Inherited (germline) CEBPA mutations are a known cause of familial AML, which can be passed from parent to child. The CEBPA Mutation Detection Test can help identify such inherited mutations, and additional genetic counselling may be recommended in these situations.
Bone marrow is collected through a procedure called aspiration, usually performed at the hip bone. The skin is numbed with local anaesthesia before a needle is inserted to draw a small amount of marrow. The procedure is brief, though mild discomfort is normal. A trained doctor performs this at the collection centre.
CEBPA Mutation Detection Test: Booking, Price, and Results
